Information  X 
Enter a valid email address

Britvic plc (BVIC)

  Print      Mail a friend       Annual reports

Friday 14 June, 2019

Britvic plc

Director/PDMR Shareholding

RNS Number : 3257C
Britvic plc
14 June 2019
 

Britvic plc

LEI: 635400L3NVMYD4BVCI53

14 June 2019

 

Director/PDMR Shareholding

 

Britvic plc (the "Company") was notified on 13 June 2019 that Clive Hooper, a Person Discharging Managerial Responsibility ("PDMR"), sold 4,503 ordinary shares of 20 pence each in the Company ("Shares") at a price of £9.22 per share on 30 May 2019. 

The attached notification, made in accordance with Article 19(3) of the EU Market Abuse Regulation, provides further information.

 

Jonathan Adelman

Company Secretary

 

 

 

1.    Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Clive Hooper

Reason for the notification

(a)

Position/status

Chief Supply Chain Officer, PDMR

(b)

Initial notification/Amendment

Initial notification

2.         Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name

Britvic plc

(b)

LEI

635400L3NVMYD4BVCI53

3.         Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 20 pence each

 

 

ISIN: GB00B0N8QD54

(b)

Nature of the transaction

Sale of shares

(c)

Price(s) and volume(s)

Price(s)

£9.22

 

Volume(s)

4,053

 

(d)

Aggregated information

-     Aggregated volume

-     Price

 

n/a

 

 

(e)

Date and time of the transaction

2019/05/30

(f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHGMGMVLDDGLZG

a d v e r t i s e m e n t